Novo Holdings reached a definitive agreement to acquire Benchmark Genetics—a premier global aquaculture breeding and salmonid genetics enterprise previously owned by Benchmark Holdings plc—for a substantial enterprise value reaching up to £260 million. This strategic transaction bolsters Novo Holdings' planetary health investment portfolio, focusing on sustainable food production, resource efficiency, and advanced aquaculture technology solutions worldwide.